Novel therapeutic strategies for ccRCC through integration of systemic drug combinations and oncolytic adenovirus immunotherapy.

Feodoroff M, Mogollon I, Hamdan F, Luck TJ, Kumari R, Bottega P, Sandberg J, Romppanen E, Paavolainen L, Malmstedt M, Penttilä P, Kallioniemi O, Mirtti T, Rannikko A, Grönholm M, Cerullo V, Pietiäinen V.

Open source

DOI: 10.3389/fimmu.2026.1760889
Published: 2026-08-14
Container: Front Immunol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1760889,
  title = {Novel therapeutic strategies for ccRCC through integration of systemic drug combinations and oncolytic adenovirus immunotherapy.},
  author = {Feodoroff M and  Mogollon I and  Hamdan F and  Luck TJ and  Kumari R and  Bottega P and  Sandberg J and  Romppanen E and  Paavolainen L and  Malmstedt M and  Penttilä P and  Kallioniemi O and  Mirtti T and  Rannikko A and  Grönholm M and  Cerullo V and  Pietiäinen V.},
  year = {2026},
  journal = {Front Immunol},
  doi = {10.3389/fimmu.2026.1760889},
  url = {https://doi.org/10.3389/fimmu.2026.1760889}
}

RIS

TY  - JOUR
TI  - Novel therapeutic strategies for ccRCC through integration of systemic drug combinations and oncolytic adenovirus immunotherapy.
AU  - Feodoroff M
AU  -  Mogollon I
AU  -  Hamdan F
AU  -  Luck TJ
AU  -  Kumari R
AU  -  Bottega P
AU  -  Sandberg J
AU  -  Romppanen E
AU  -  Paavolainen L
AU  -  Malmstedt M
AU  -  Penttilä P
AU  -  Kallioniemi O
AU  -  Mirtti T
AU  -  Rannikko A
AU  -  Grönholm M
AU  -  Cerullo V
AU  -  Pietiäinen V.
PY  - 2026
JO  - Front Immunol
DO  - 10.3389/fimmu.2026.1760889
UR  - https://doi.org/10.3389/fimmu.2026.1760889
ER  -

APA

M, F., I, M., F, H., TJ, L., R, K., P, B., J, S., E, R., L, P., M, M., P, P., O, K., T, M., A, R., M, G., V, C., & V., P. (2026). Novel therapeutic strategies for ccRCC through integration of systemic drug combinations and oncolytic adenovirus immunotherapy.. Front Immunol. https://doi.org/10.3389/fimmu.2026.1760889

Source records

europe-pmc · retrieved 2026-09-27T05:58:36.225Z
doaj · retrieved 2026-09-27T05:58:36.236Z